Service Overview: Lung Cancer
Lung cancer remains one of the deadliest cancers due to late detection. BridgeInDx is building AI-powered tests that combine biomarker panels with patient risk factors such as smoking history, age, and tuberculosis exposure. These tests will enable earlier detection and triage, giving patients a better chance at effective treatment.
